[Clinical use of ornithine-8-vasopressin in addition to a local anesthetic in neurosurgery].
D000328:Adult; D000698:Analgesia; D000768:Anesthesia, General; D000779:Anesthetics, Local / Q000627:therapeutic use*; D001794:Blood Pressure; D001927:Brain Diseases / Q000601:surgery*; D001932:Brain Neoplasms / Q000601:surgery*; D003399:Craniotomy; D004837:Epinephrine / Q000627:therapeutic use; D005260:Female; D006470:Hemorrhage / Q000139:chemically induced / Q000188:drug therapy; D006487:Hemostasis; D006801:Humans; D008297:Male; D008875:Middle Aged; D009952:Ornithine / Q000627:therapeutic use*; D010167:Pallor / Q000209:etiology; D010300:Parkinson Disease / Q000601:surgery; D011183:Postoperative Complications / Q000188:drug therapy; D011674:Pulse; D013238:Stereotaxic Techniques; D014207:Trephining; D014662:Vasoconstrictor Agents / Q000627:therapeutic use; D014667:Vasopressins / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D014945:Wound Healing
D000779:Anesthetics, Local; D014662:Vasoconstrictor Agents; D014667:Vasopressins; D009952:Ornithine; D004837:Epinephrine
Ergebnisse der klinischen Anwendung des Zusatzes Orntihin-8-Vasopressin zum Lokalanästhetikum bei neurochirurgischen Operationen.